Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 14476 - 14500 of 15036 in total

(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE

Experimental

2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide

Experimental

4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid

Experimental

N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide

Experimental

1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE

Experimental

4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid

Experimental

N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide

Experimental

Flumequine

Flumequine is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class used to treat bacterial infections.
Withdrawn

Pyridoxamine

Pyridoxamine has been used in trials studying the treatment of Kidney Stones.
Investigational

Vistusertib

Vistusertib is under investigation for the treatment of Advanced Gastric Adenocarcinoma.
Investigational

Losmapimod

Losmapimod has been investigated for the prevention of Chronic Obstructive Pulmonary Disease.
Investigational

Phthalocyanine

Phthalocyanine is under investigation in clinical trial NCT00103246 (Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides).
Investigational

Methyl-[4-(4-Piperidine-1-Ylmethyl-Phenyl)-Cyclohexyl]-Carbaminic Acid-(4-Chlorophenyl)-Ester

Experimental

2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID

Experimental

N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine

Experimental

p-Nitrophenylacetic acid

Experimental

4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE

Experimental

3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID

Experimental

2-(3-NITROPHENYL)ACETIC ACID

Experimental

123I-iodometomidate

123I-iodometomidate is under investigation in clinical trial NCT00454103 (Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy).
Investigational

AMG-131

AMG-131 (T131), an orally-administered therapy, is expected to lower blood glucose in type II diabetic patients by improving the body’s ability to respond to insulin. T131 is a selective modulator of PPARg (peroxisome proliferator activated receptor gamma), a receptor involved in regulating the body’s ability to respond to insulin. T131...
Investigational
Matched Description: … is not structurally related to the thiazolidinedione class of PPARg agonists, which includes Actos and …

2,6-Diamino-8-Propylsulfanylmethyl-3h-Quinazoline-4-One

Experimental

1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine

Experimental

1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine

Experimental

Simfibrate

Experimental
Displaying drugs 14476 - 14500 of 15036 in total